Tg Therapeutics shares owned by Envestnet Asset Management
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Envestnet Asset Management
from 13F filings
Historical chart of Envestnet Asset Management investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tg Therapeutics by Envestnet Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 45k | 23.39 |
| 2024-06-30 | $674k | 38k | 17.79 |
| 2024-03-31 | $591k | 39k | 15.21 |
| 2023-09-30 | $346k | 41k | 8.36 |
| 2023-06-30 | $691k | 28k | 24.84 |
| 2023-03-31 | $238k | 16k | 15.04 |
| 2022-12-31 | $124k | 11k | 11.83 |
| 2021-09-30 | $285k | 8.6k | 33.24 |
| 2021-06-30 | $482k | 12k | 38.81 |
| 2021-03-31 | $526k | 11k | 48.22 |
| 2020-12-31 | $351k | 6.8k | 51.97 |
More positions owned by Envestnet Asset Management
View all positions for Envestnet Asset Management